{"date":"2026-05-15","count":34,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6827-2026-05-15-2225-12arve1","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-15","time":"22:25:01","subject":"公告本公司MPB-1523 MRI顯影劑-肝細胞癌接獲美國FDA Type C meeting會議記錄","clause":"第8款","fact_date":"2026-05-15","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2026-05-15 22:25，「公告本公司MPB-1523 MRI顯影劑-肝細胞癌接獲美國FDA Type C meeting會議記錄」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-05-15-2138-io820o","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-05-15","time":"21:38:29","subject":"代子公司佐登妮絲(廣州)美容化妝品有限公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第二款及第三款之規定公告","clause":"第23款","fact_date":"2026-05-15","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-05-15 21:38，「代子公司佐登妮絲(廣州)美容化妝品有限公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第二款及第三款之規定公」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-05-15-2138-ofgaj3","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-05-15","time":"21:38:12","subject":"代子公司佐登妮絲國際股份有限公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第二款及第三款之規定公告","clause":"第23款","fact_date":"2026-05-15","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-05-15 21:38，「代子公司佐登妮絲國際股份有限公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第二款及第三款之規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-05-15-2116-1xfc2zj","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-05-15","time":"21:16:40","subject":"公告本公司董事會決議委任薪酬委員會委員名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-05-15 21:16，「公告本公司董事會決議委任薪酬委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-05-15-2116-p3pl10","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-05-15","time":"21:16:27","subject":"公告本公司審計委員會委員名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-05-15 21:16，「公告本公司審計委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-05-15-2116-9769qc","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-05-15","time":"21:16:14","subject":"公告本公司董事會選任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-05-15 21:16，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-05-15-2115-136k05h","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-05-15","time":"21:15:57","subject":"公告本公司股東常會通過解除新任董事競業禁止之限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-05-15 21:15，「公告本公司股東常會通過解除新任董事競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-05-15-2115-7sf6el","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-05-15","time":"21:15:38","subject":"公告本公司115年股東常會全面改選董事(含獨立董事)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-05-15 21:15，「公告本公司115年股東常會全面改選董事(含獨立董事)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-05-15-2115-1yv5nvm","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-05-15","time":"21:15:23","subject":"本公司115年股東常會決議通過辦理減資彌補虧損致債權人公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-05-15 21:15，「本公司115年股東常會決議通過辦理減資彌補虧損致債權人公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-05-15-2115-3il1nf","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-05-15","time":"21:15:06","subject":"公告本公司115年度股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-05-15 21:15，「公告本公司115年度股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-05-15-2029-1ythr6l","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-05-15","time":"20:29:53","subject":"公告本公司因配合會計師事務所內部輪調更換會計師","clause":"第7款","fact_date":"2026-05-15","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-05-15 20:29，「公告本公司因配合會計師事務所內部輪調更換會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-05-15-2025-1oishop","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-05-15","time":"20:25:34","subject":"代重要子公司Belite Bio, Inc公告受邀參加第27屆眼底病論壇暨國際視網膜研討會（Retina China 2026）","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-05-15 20:25，「代重要子公司Belite Bio, Inc公告受邀參加第27屆眼底病論壇暨國際視網膜研討會（Retina China 2」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-05-15-1852-13h3f0n","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-05-15","time":"18:52:00","subject":"公告本公司115年4月份自結應收帳款餘額及回收情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-05-15 18:52，「公告本公司115年4月份自結應收帳款餘額及回收情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-05-15-1742-12aj2h2","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-05-15","time":"17:42:31","subject":"代重要子公司永信藥品工業股份有限公司公告委外廠商活動網站消費者資訊外流事宜","clause":"第51款","fact_date":"2026-05-15","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-05-15 17:42，「代重要子公司永信藥品工業股份有限公司公告委外廠商活動網站消費者資訊外流事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2026-05-15-1726-1gg4fv4","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2026-05-15","time":"17:26:53","subject":"更正本公司115年第1季會計師查核報告意見類型","clause":"第51款","fact_date":"2026-05-15","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2026-05-15 17:26，「更正本公司115年第1季會計師查核報告意見類型」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2026-05-15-1703-1xiu65","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2026-05-15","time":"17:03:40","subject":"本公司受邀參加5/18永豐金證券舉辦之線上法說會(更正主旨)","clause":"第53款","fact_date":"2026-05-15","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2026-05-15 17:03，「本公司受邀參加5/18永豐金證券舉辦之線上法說會(更正主旨)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2026-05-15-1700-54swv6","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2026-05-15","time":"17:00:40","subject":"公告本公司法人董事改派代表人","clause":"第6款","fact_date":"2026-05-15","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2026-05-15 17:00，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2026-05-15-1700-kxgk3x","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2026-05-15","time":"17:00:07","subject":"公告本公司發言人及代理發言人異動","clause":"第8款","fact_date":"2026-05-15","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2026-05-15 17:00，「公告本公司發言人及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-05-15-1646-vm380h","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-05-15","time":"16:46:02","subject":"公告本公司115年第一次現金增資案委託代收股款及存儲專戶行庫","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-05-15 16:46，「公告本公司115年第一次現金增資案委託代收股款及存儲專戶行庫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2026-05-15-1556-1jthdie","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2026-05-15","time":"15:56:41","subject":"本公司受邀參加5/12永豐金證券舉辦之線上法說會","clause":"第12款","fact_date":"2026-05-18","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2026-05-15 15:56，「本公司受邀參加5/12永豐金證券舉辦之線上法說會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-05-15-1529-18c9mlu","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-05-15","time":"15:29:21","subject":"公告本公司董事會決議第三次買回庫藏股","clause":"第35款","fact_date":"2026-05-15","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-05-15 15:29，「公告本公司董事會決議第三次買回庫藏股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-05-15-1528-6fg0mx","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-05-15","time":"15:28:16","subject":"公告本公司股票初次上櫃現金增資股款委託代收及存儲價款機構","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-05-15 15:28，「公告本公司股票初次上櫃現金增資股款委託代收及存儲價款機構」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-05-15-1516-1cm8031","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-05-15","time":"15:16:09","subject":"代重要子公司高峰藥品材料股份有限公司公告股東會決議通過解除董事競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-05-15 15:16，「代重要子公司高峰藥品材料股份有限公司公告股東會決議通過解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-05-15-1515-1x94z16","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-05-15","time":"15:15:45","subject":"代重要子公司高峰藥品材料股份有限公司公告除(權)息基準日相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-05-15 15:15，「代重要子公司高峰藥品材料股份有限公司公告除(權)息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-05-15-1515-xgm4o8","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-05-15","time":"15:15:23","subject":"代重要子公司高峰藥品材料股份有限公司公告115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-05-15 15:15，「代重要子公司高峰藥品材料股份有限公司公告115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4183-2026-05-15-1437-15z4jkg","company_id":"4183","company":"福永生技","market":"上櫃","industry":"生技醫療","date":"2026-05-15","time":"14:37:20","subject":"本公司薪酬委員會委員辭任","clause":"第6款","fact_date":"2026-05-15","cite_as":"公開資訊觀測站重大訊息：福永生技（4183），2026-05-15 14:37，「本公司薪酬委員會委員辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-05-15-1436-1fygsm9","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-05-15","time":"14:36:42","subject":"本公司創新板上市掛牌首五個營業日穩定價格操作結果","clause":"第51款","fact_date":"2026-05-15","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-05-15 14:36，「本公司創新板上市掛牌首五個營業日穩定價格操作結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-05-15-1419-4il621","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-05-15","time":"14:19:34","subject":"本公司生物相似性藥品「益康平凍晶注射劑 420毫克(EIRGASUN vial 420 mg)」獲衛生福利部中央健康保險署核准納入健保給付","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-05-15 14:19，「本公司生物相似性藥品「益康平凍晶注射劑 420毫克(EIRGASUN vial 420 mg)」獲衛生福利部中央健康保險」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-05-15-1415-9h0ctm","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-05-15","time":"14:15:15","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-15","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-05-15 14:15，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6733-2026-05-15-1343-k7lfse","company_id":"6733","company":"博晟生醫","market":"上櫃","industry":"生技醫療","date":"2026-05-15","time":"13:43:29","subject":"更正本公司115年第一季財務報告公告內容及IFRSiXBRL申報資訊(每股淨值)。","clause":"第53款","fact_date":"2026-05-15","cite_as":"公開資訊觀測站重大訊息：博晟生醫（6733），2026-05-15 13:43，「更正本公司115年第一季財務報告公告內容及IFRSiXBRL申報資訊(每股淨值)。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2026-05-15-1036-1fqkmsr","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-15","time":"10:36:07","subject":"澄清媒體報導","clause":"第26款","fact_date":"2026-05-15","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2026-05-15 10:36，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2026-05-15-1028-1fqkmsr","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2026-05-15","time":"10:28:02","subject":"澄清媒體報導","clause":"第51款","fact_date":"2026-05-14","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2026-05-15 10:28，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2026-05-15-0853-1p6s3p7","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2026-05-15","time":"08:53:56","subject":"公告本公司辦理股票初次創新版上市過額配售內容","clause":"第44款","fact_date":"2026-05-15","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2026-05-15 08:53，「公告本公司辦理股票初次創新版上市過額配售內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2026-05-15-0853-196vdzb","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2026-05-15","time":"08:53:12","subject":"公告本公司股票初次創新板上市前現金增資員工認購股款催繳相關事宜","clause":"第44款","fact_date":"2026-05-15","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2026-05-15 08:53，「公告本公司股票初次創新板上市前現金增資員工認購股款催繳相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}